Defective interferon signaling in the circulating monocytes of type 2 diabetic mice.
Shunsuke OmodakaYuya KatoYoshimichi SatoJaime Falcone-JuengertHongxia ZhangAtsushi KanokeWalter L EckalbarHidenori EndoChristine L HsiehDvir AranJialing LiuPublished in: bioRxiv : the preprint server for biology (2024)
The mechanisms involved in the detrimental diabetic effect on stroke are largely unclear. We show here, for the first time, that peripheral monocytes have disproportionally altered the subsets and changed transcriptome under diabetes and/or stroke conditions. Moreover, genes in the IFN-related signaling pathways are suppressed in the diabetic monocytes, which underscores the immunosuppression and impaired ischemic tolerance under the T2DM condition. Our data raise a possibility that malfunctioned monocytes may systemically and focally affect the host, leading to the poor outcome of diabetes in the setting of stroke. The results yield important clues to molecular mechanisms involved in the detrimental diabetic effect on stroke outcome.
Keyphrases
- type diabetes
- atrial fibrillation
- dendritic cells
- peripheral blood
- glycemic control
- cardiovascular disease
- wound healing
- cerebral ischemia
- gene expression
- genome wide
- immune response
- single cell
- metabolic syndrome
- electronic health record
- brain injury
- blood brain barrier
- transcription factor
- rna seq
- ischemia reperfusion injury
- data analysis
- endoplasmic reticulum stress
- induced apoptosis
- chemotherapy induced